水溶性金属卟啉拮抗hIAPP毒性的机理及构效关系研究
批准号:
32071282
项目类别:
面上项目
资助金额:
58.0 万元
负责人:
李海玲
依托单位:
学科分类:
无机生物化学与环境测控
结题年份:
2024
批准年份:
2020
项目状态:
已结题
项目参与者:
李海玲
中文摘要
人胰岛淀粉样蛋白(hIAPP)聚集和氧化/硝化应激,是2型糖尿病(T2D)的重要病理特征。抑制聚集和减少氧化/硝化应激药物能够防治T2D。最近我们发现铁卟啉可以有效抑制hIAPP的聚集,但因其具有细胞毒性而无法用于治疗T2D。一些水溶性金属卟啉可以安全用于动物体内的过氧亚硝酸根(ONOO-)清除,能够减轻体内氧化/硝化应激。我们推测这些水溶性金属卟啉可以作为具有抑制hIAPP聚集和清除ONOO-的双功能药物。本项目拟选择不同衍生基团和不同金属中心的水溶性金属卟啉,通过多种现代分析测试手段,研究不同的衍生基团和不同的金属中心对金属卟啉抑制hIAPP聚集能力和抑制hIAPP损伤生物膜的能力差异,然后在胰岛β细胞上研究并验证这些金属卟啉是否具有抑制外源性和内源性hIAPP导致的细胞功能丧失和死亡。本研究可阐明金属卟啉抑制hIAPP聚集和细胞毒性的构效关系,为寻找新的防治T2D的药物提供科学依据。
英文摘要
Human islet amyloid polypeptide (hIAPP) aggregation and oxidative stress, as well as nitrative stress, are important pathology features of type 2 diabetes (T2D), and anti-aggregation compounds are thought to be beneficial to inhibit T2D. Recently we found that iron porphyrin inhibited hIAPP aggregation effectively, but iron porphyrin is toxic to islet -cells. Some metal porphyrin water-soluble derivatives, which had been found to be active peroxynitrite (ONOO-) decomposers, had been safely used as ONOO- scavengers in vivo. Considering the similar structure with iron porphyrin, we hypothesis that these metal porphyrin water-soluble derivatives could be used to inhibit hIAPP aggregation. Besides, with the ONOO- scavenging activity, these water-soluble metalloporphyrins may act as duel function compounds to inhibit hIAPP aggregation and ONOO- caused oxidation and protein tyrosine nitration. Thus, these water-soluble metalloporphyrins may be ideal candidates for preventing T2D. To confirm our hypothesis, we’ll: (1) study the binding properties between hIAPP and metal porphyrins, as well as their structure-active relationship on scavenging ONOO-; (2) study their structure-active relationship on inhibiting hIAPP aggregation; (3) study their structure-active relationship on inhibiting hIAPP caused membrane damage; (4) study the roles of the interaction between hIAPP and metal porphyrins in mitochondrion function, protein oxidation and nitration on rat insulinoma INS-1 cell. These studies will not only provide structure-activity of metal porphyrin water-soluble derivatives on inhibiting hIAPP aggregation and its cytotoxicity, but also are important for providing scientific basis and new therapeutic agents for preventing and curing of T2D.
人胰岛淀粉样蛋白(hIAPP)聚集和氧化/硝化应激,是2型糖尿病(T2D)的重要病理特征,抑制聚集和减少氧化/硝化应激药物能够防治T2D。基于一些水溶性金属卟啉可以安全用于动物体内的过氧亚硝酸根(ONOO-)清除,能够减轻体内氧化/硝化应激,我们推测这些水溶性金属卟啉可以作为具有抑制hIAPP聚集和清除ONOO-的双功能药物。本项目从化学体系到细胞水平,系统研究了一系列结构和金属中心不同的水溶性金属卟啉对hIAPP聚集的抑制及hIAPP细胞毒性的抑制的效果及其作用机理。发现当配体相同时,铁中心的卟啉比锰中心卟啉有更好的抑制hIAPP聚集及降低hIAPP细胞毒性的功能,而当金属相同时,在生理pH条件下带负电荷配体效果好于带正电荷配体。配体上带有邻二酚结构将有助于发挥其抑制聚集的能力。本项目阐明了金属卟啉抑制hIAPP聚集和细胞毒性的构效关系,提出生理pH条件下带负电荷的水溶性铁卟啉可以作为抑制hIAPP聚集和清除ONOO-的双功能药物。
基于蛋白质酪氨酸硝化的铁过载促进胰岛素抵抗的分子机制及黄芩苷的干预作用研究
-
批准号:31570810
-
项目类别:面上项目
-
资助金额:62.0万元
-
批准年份:2015
-
负责人:李海玲
-
依托单位:
国内基金
海外基金